期刊文献+

颅内动脉瘤患者COL1A2基因rs42524位点多态性检测与分析

Detection and analysis of the polymorphism of rs42524 of type I collagen alpha2 gene in intracranial aneurysms
原文传递
导出
摘要 目的I型胶原蛋白以链(COL1A2)基因已被证明与日本家族性颅内动脉瘤的发病机制相关,在中国汉族颅内动脉瘤患者中检测与分析COL1A2基因rs42524位点C/G多态性。方法利用PCR—RFLP方法,比较226例颅内动脉瘤与326例正常对照之间COL1A2基因rs42524位点的基因型及等位基因频率的构成。结果在动脉瘤组和对照组之间rs42524位点的GC+CC基因型频率分布差异有统计学意义(16.37%:7.06%,Χ^2=11.99,P=0.002),C等位基因频率分布差异也有统计学意义(8.63%:3.68%,Χ^2=11.96,P=0.001)。用logistic回归纠正性别和年龄因素结果没有改变。结论在中国汉族人群中颅内动脉瘤组和对照组之间COL1A2基因的rs42524位点多态性差异有统计学意义。 Objective Type I Collagen alpha2 (COL1A2) gene on chromosome 7q22. 1 had been showed to be associated with Japanese familial intracranial aneurysms. In this study, the purpose was to detect and analyze the polymorphism of rs42524 of I COL1A2 gene in intracranial aneurysms in Chinese Hart nationality. Methods To compare the genotype frequency and C allele frequency of polymorphism of rs42524 of COL1A2 in 226 patients with intracranial aneurysms and 326 controls by polymerase chain reaction - restriction fragment length polymorphism ( PCR - RFLP ) method. Results The GC + CC genotype frequency of aneurysm group ( 16. 37% ) was much higher than that of the control group (7.06%) ( Χ^2 = 11.96, P = 0. 001 ) . The C allele frequency of aneurysm group ( 8. 63% ) was also higher than that of the control group ( 3.68% ) (Χ^2 = 10. 75, P = 0. 001 ). Adjustment for age and sex using logistic regression did not change the conclusions (Χ^2 = 10. 90, P = 0. 001 ). Conclusion There is significant difference of polymorphism rs42524 of COL1A2 between intracranial aneurysms and controls in Chinese Han nationality. The variant COL1A2 gene could be a genetic risk factor for intracranial aneurisms.
出处 《中华神经外科杂志》 CSCD 北大核心 2009年第12期1118-1121,共4页 Chinese Journal of Neurosurgery
基金 国家自然科学基金(30973109) 山东省科技厅科技攻关重点项目(2004GG2202140)
关键词 颅内动脉瘤 I型胶原蛋白α2链基因 单核苷酸多态性 Intracranial aneurysm COL1A2 Single nucleotide polymorphism
  • 相关文献

参考文献16

  • 1郭付有,郭予大,游潮.颅内动脉瘤发病机制的研究进展[J].中国脑血管病杂志,2004,1(10):472-476. 被引量:14
  • 2Dalgleish R. The human type Ⅰ collagen mutation database. Nucleic Acids Res, 1997, 25 : 181-187.
  • 3Gajko-Galicka A. Mutations in type Ⅰ collagen genes resulting in osteogenesis impeffecta in humans. Acta Biochim Pol,2002, 49: 433-441.
  • 4朱玉方,庞琦.胶原蛋白基因与颅内动脉瘤形成的关系[J].中国脑血管病杂志,2008,5(5):233-236. 被引量:5
  • 5Sunyaev S, Ramensky V, Koch I, et al. Prediction of deleterious human alleles. Hum Mol Genet,2001,10 : 591-597.
  • 6张宇,诸葛启钏,瞿宣兴,赵继宗,郑伟明,钟鸣,吴近森.脑动脉瘤病理改变与基质金属蛋白酶(MMPs)的表达[J].温州医学院学报,2003,33(2):94-96. 被引量:14
  • 7Ruigrok YM, Rinkcl GJE, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol, 2005, 4 : 179-189.
  • 8Yoneyama T, Kasuya H, Onda H, et al. Collagen type Ⅰ alpha2 (COL1A2) is the susceptible gene for intracranial aneurysms. Stroke, 2004, 35: 443-448.
  • 9Kuhlenbaumer G, Konrad C, Krmera S, et al. The col1A2 polymorphism rs42524, which is associated with lAs, shows no association with sCAD. J Neurol Neurosurg Psychiatry, 2006, 77: 124-125.
  • 10Hofer A, Hermans M, Kubassek N, et al. Elastin polymorphism haplotype and intracranial aneurysms are not associated in central Europe. Stroke, 2003, 34: 1207-1211.

二级参考文献57

  • 1[1]Cohen JR, Mandell C, Margolis I, et al. Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms[J]. Surg Gynecol Obstet, 1987,164(4) :355 - 358.
  • 2[2]Stehbens WE. Pathology and pathogenesis of intracranial berry aneurysms[J]. Neurol Res, 1990,12(1) :29- 34.
  • 3[3]Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic leisions of cerebral berry aneurysms[J]. J Neuropathol Exp Neurol, 1994,53(4) :399 - 406.
  • 4[4]Brown PD, Levy AT, Margulies IM, et al. Independent expression and cellular processing of Mr 72000 type Ⅳ collagenase and interstitial collagenase in human tumorigenic cell lines[J]. Cancer Res, 1990,50(19) :6184 - 6191.
  • 5[5]Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid , macrophage , and smooth muscle cell content[J]. Br Heart J, 1993,69(5):377-381.
  • 6[6]Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques[J]. J Clin Invest, 1994,94(6):2394-2503.
  • 7[7]Schievink WI, Prakash UB, Piepgras DG, et al. Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection[J].Lancet, 1994,343 (8895) :452 - 453.
  • 8[8]Schievink WI, Katzmann JA, Piepgras DG, et al. Alpha 1-antitrypsin phenotypes among patients with intracranial aneurysms[J]. J Neurosurg, 1996,84(5) :781 - 784.
  • 9[9]Connolly ES, Fiore AJ, Winfree CJ, et al. Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase[J]. Neurosurgery, 1997,40(5): 903-909.
  • 10[10]Trehame GD, Boyle JR, Goodall S, et al. Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease[ J]. Br J Surg, 1999,86(8): 1053 - 1058.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部